[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-428020-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-428020-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","factors-influencing-the-participation-of-black-older-adults-in-clinical-trials-on-dementia","FACTORS INFLUENCING THE PARTICIPATION OF BLACK OLDER ADULTS IN CLINICAL TRIALS ON DEMENTIA","","Study findings analyze barriers and facilitators influencing Black older adults’ participation in dementia clinical trials. Using interviews with Black older adults who consented to referral, the research team identified practical access issues, trust and understanding concerns, and logistical constraints, alongside motivations such as desire for medications, recognition of clinical trial importance, comfort with race-concordant researchers, and personal exposure to dementia. ATLAS-ti inductive/deductive transcript analysis informed conclusions emphasizing strong links between trialists and Black communities and the need for interdisciplinary partnerships to advance social justice.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/factors-influencing-the-participation-of-black-older-adults-in-clinical-trials-on-dementia/428020/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/factors-influencing-the-participation-of-black-older-adults-in-clinical-trials-on-dementia/428020.png","ImageObject",300,407,{"name":42,"@type":43},"Aditya","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-29",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study designed to identify?","Question",{"text":63,"@type":64},"The study aimed to identify barriers and facilitators to participating in dementia clinical trials from the perspective of Black older adults who agreed to referral.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were interview data analyzed?",{"text":68,"@type":64},"Interview transcripts were analyzed in ATLAS-ti using inductive and deductive content analysis approaches.",{"name":70,"@type":61,"acceptedAnswer":71},"What barriers reduced participation?",{"text":72,"@type":64},"Reported barriers included limited connections with clinical trialists, logistical constraints, and limited trust and understanding of participating in clinical trials.",{"name":74,"@type":61,"acceptedAnswer":75},"What factors supported participation?",{"text":76,"@type":64},"Facilitators included wanting medications, understanding the importance of participating in clinical trials, interacting with race-concordant researchers, and personal exposure to dementia.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},428020,1790862990,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,104,109,113,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":101,"show_sort_weight":102,"slug":103},"Comic",60,"comic",{"id":105,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},6,"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":111,"slug":112},7,40,"healthcare",{"id":114,"doc_module":4,"doc_module_name":25,"category_name":115,"show_sort_weight":116,"slug":117},8,"Research & Report",30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":55,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":110,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":22,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":30,"preview_page_count":4},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Innovation in Aging, 2025, Vol. 9, No. S2 1269  \nthe Alzheimer’s Association. Methods: Interviews of Black older adults who agreed to be referred to the clinical trial identified barriers/facilitators to enroll in the trial after allowing our team to forward their details to the trialists. Interview transcripts were analyzed in ATLAS-ti with inductive/deductive content analysis. Results: In April-May 2024, a Black researcher contacted the 43 older adults who agreed to be referred to the trial. She interviewed 17 study participants who self-reported as Black/African American (average age 69, 70% new to research) . Facilitators included: wanting medications, understanding the importance of participating in clinical trials, interacting with race-concordant researchers, personal exposure to dementia. Barriers included: limited connections with clinical trialists, logistical constraints, limited trust and understanding of participating in clinical trials. Conclusions: Findings underscore the importance of strong connections between clinical trialists and Black communities, as well as the salience of interdisciplinary partnerships to achieve social justice.  \nAbstract citation ID: igaf122.4237  \nFACTORS INFLUENCING THE PARTICIPATION OF  \nBLACK OLDER ADULTS IN CLINICAL TRIALS ON  \nDEMENTIA  \nElena Portacolone1, Julio Rojas-Martinez1, Kim Scott2, Thi Tran1, and Catherine Waters1, 1. University of California, San Francisco, San Francisco, California, United States, 2. Bay Area Black Nurses Association, San Francisco, California, United States  \nBackground: Black communities are twice as likely as Whites to have dementia and represent 13% of the US population, constituting only 5% of participants in clinical trials on dementia.  \nThe goal of this study was to identify barriers and facilitators to participating in the a clinical trial on dementia from the perspective of Black older adults who agreed to be referred to the trialists who were testing a drug to treat Alzheimer’s disease. Between 5/1/2023-1/31/2024, we raised awareness of Black communities about the option of being referred by our team to the trial via events endorsed by the National Black Nursing Association and","cbCairZXDDoaJEkP","https://ap.wps.com/l/cbCairZXDDoaJEkP","pdf",1112054,"English","# Background\n# Study goal\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What was the study designed to identify?\",\"answer\":\"The study aimed to identify barriers and facilitators to participating in dementia clinical trials from the perspective of Black older adults who agreed to referral.\"},{\"question\":\"How were interview data analyzed?\",\"answer\":\"Interview transcripts were analyzed in ATLAS-ti using inductive and deductive content analysis approaches.\"},{\"question\":\"What barriers reduced participation?\",\"answer\":\"Reported barriers included limited connections with clinical trialists, logistical constraints, and limited trust and understanding of participating in clinical trials.\"},{\"question\":\"What factors supported participation?\",\"answer\":\"Facilitators included wanting medications, understanding the importance of participating in clinical trials, interacting with race-concordant researchers, and personal exposure to dementia.\"}]","FACTORS INFLUENCING THE PARTICIPATION OF BLACK OLDER ADULTS IN CLINICAL TRIALS ON DEMENTIA | PDF",1790645537]